Literature DB >> 3331969

Ability of the electrocardiogram to detect myocardial lesions in isoproterenol induced rat cardiomyopathy.

R B Bestetti1, C P Ramos, J Figuerêdo-Silva, V N Sales-Neto, J S Oliveira.   

Abstract

Resting electrocardiograms were recorded in 18 male adult rats injected subcutaneously with two doses of isoproterenol (200 mg.kg-1 body weight) 10 days before the animals were submitted to the ajmaline test (1 mg.kg-1 body weight iv). After the ajmaline test all rats were killed and the hearts examined histologically. Electrocardiographic changes were detected at rest in 72% of the isoproterenol injected rats: pathological Q waves, lengthening of the QRS complex, and QRS abnormality were found in 50%, 44%, and 44% of these animals respectively. Ajmaline induced similar changes in both control and isoproterenol treated rats (P wave enlargement (p less than 0.01 and p less than 0.001 respectively), increased PR interval (p less than 0.003 and p less than 0.001 respectively), and increased QaT interval (p less than 0.001 in both groups]. However, ajmaline caused an increase in heart rate only in isoproterenol treated rats (p less than 0.05). A pronounced increase in PR interval, not observed in control rats, was detected in one of five isoproterenol injected rats with a normal resting ECG but showing microscopical cardiac lesions. Apical aneurysm of the left ventricle was found in 16% of isoproterenol injected rats. A mononuclear inflammatory reaction was observed in 13 (72%) of the isoproterenol injected rats and was multifocal in at least three regions of the myocardium in six (46%) and disseminated throughout the myocardium in seven (53%) of these animals. When the electrocardiographic and pathological findings were compared, the ECG changes were found to have a 91% sensitivity, 83% specificity, and 91% positive predictive value.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3331969     DOI: 10.1093/cvr/21.12.916

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Prognostic Significance of Chronic Kidney Disease (CKD-EPI Equation) and Anemia in Patients with Chronic Heart Failure Secondary to Chagas Cardiomyopathy.

Authors:  Marcelo Arruda Nakazone; Maurício Nassau Machado; Ana Paula Otaviano; Ana Maria Silveira Rodrigues; Augusto Cardinalli-Neto; Reinaldo Bulgarelli Bestetti
Journal:  Cardiol Res Pract       Date:  2020-07-06       Impact factor: 1.866

2.  The ajmaline test as a method to disclose latent experimental Chagas' heart disease.

Authors:  R B Bestetti; E G Soares; V N Sales-Neto; J S Oliveira
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

3.  Cardiac resynchronization therapy for patients with chronic systolic heart failure secondary to Chagas cardiomyopathy in the 21st century.

Authors:  Reinaldo B Bestetti
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jan-Mar

4.  Clinical predictors of inducible sustained ventricular tachycardia during electrophysiologic study in patients with chronic Chagas' heart disease.

Authors:  Augusto Cardinalli-Neto; Adalberto M Lorga-Filho; Elissandro F Silva; Renata P Lima; Eduardo Palmegiani; Reinaldo B Bestetti
Journal:  Int J Cardiol Heart Vasc       Date:  2015-10-19

5.  Simultaneous activation of the small conductance calcium-activated potassium current by acetylcholine and inhibition of sodium current by ajmaline cause J-wave syndrome in Langendorff-perfused rabbit ventricles.

Authors:  Yu-Dong Fei; Mu Chen; Shuai Guo; Akira Ueoka; Zhenhui Chen; Michael Rubart-von der Lohe; Thomas H Everett; Zhilin Qu; James N Weiss; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2020-08-04       Impact factor: 6.343

6.  Obstructive Sleep Apnea: A Marker of Cardiac Remodeling in Patients with Chronic Chagas Disease.

Authors:  Reinaldo B Bestetti
Journal:  Arq Bras Cardiol       Date:  2018-09       Impact factor: 2.000

7.  Does left ventricular reverse remodeling influence long-term outcomes in patients with Chagas cardiomyopathy?

Authors:  Marcelo Arruda Nakazone; Ana Paula Otaviano; Maurício Nassau Machado; Reinaldo Bulgarelli Bestetti
Journal:  Cardiol J       Date:  2020-03-24       Impact factor: 2.737

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.